Systematic Literature Review on Buprenorphine/naloxone Use in Outpatient Opioid Dependence Treatment

被引:0
|
作者
Main, Fiona [1 ]
Kelly, Len
机构
[1] Northern Ontario Sch Med, Family Med, Sudbury, ON, Canada
关键词
addiction; opioid substitution therapy; buprenorphine/naloxone; outpatient;
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: Summarize the literature on buprenorphine/ naloxone for outpatient treatment of opioid dependence disorder. Methods: a literature of EMBASE and Medline 2000-2014 using the terms "naloxone + buprenorphine" and "opioid-related disorders". Results: Over two hundred articles were retrieved. Seventeen studies were ultimately selected and reviewed for study quality, using Downs and Black's 1998 checklist, the Canadian Task Force on Preventive Health Care levels of evidence and study outcome analysis. Conclusion: Buprenorphine/naloxone appears to be a safe, effective treatment modality for treatment of opioid dependence. As a recently introduced medication in North America, clinicians are slow to fully embrace it use. It provides an opportunity to more widely provide opioid substitution therapy in primary care settings.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [41] Buprenorphine/Naloxone for Opioid Use Disorder Among Alaska Native and American Indian People
    Lillie, Kate M.
    Shaw, Jennifer
    Jansen, Kelley J.
    Garrison, Michelle M.
    JOURNAL OF ADDICTION MEDICINE, 2021, 15 (04) : 297 - 302
  • [42] Retinal nerve fiber layer decrease and choroidal layer increase after four weeks of buprenorphine/naloxone maintenance treatment in opioid use disorder
    Orum, Mehmet Hamdi
    Kalenderoglu, Aysun
    Karadag, Ayse Sevgi
    Hocaoglu, Cicek
    EUROPEAN JOURNAL OF PSYCHIATRY, 2022, 36 (04) : 260 - 270
  • [43] Mediating effect of craving on the impact of buprenorphine/naloxone and methadone treatment on opioid use: Results from a randomized controlled trial
    McAnulty, Christina
    Bastien, Gabriel
    Ledjiar, Omar
    Socias, M. Eugenia
    Le Foll, Bernard
    Lim, Ron
    Jutras-Aswad, Didier
    ADDICTIVE BEHAVIORS, 2024, 154
  • [44] Comparison of naltrexone implant and oral buprenorphine-naloxone in the treatment of opiate use disorder
    Erdogan, Ali
    Topcuoglu, Muge
    Coskun, Mustafa Nogay
    Cinemre, Buket
    Kulaksizoglu, Burak
    Kuloglu, Mehmet Murat
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2022, 37 (02)
  • [45] The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale
    Socias, M. Eugenia
    Ahamad, Keith
    Le Foll, Bernard
    Lim, Ron
    Bruneau, Julie
    Fischer, Benedikt
    Wild, T. Cameron
    Wood, Evan
    Jutras-Aswad, Didier
    CONTEMPORARY CLINICAL TRIALS, 2018, 69 : 21 - 27
  • [46] Buprenorphine adherence and illicit opioid use among patients in treatment for opioid use disorder
    Bhatraju, Elenore P.
    Radick, Andrea C.
    Leroux, Brian G.
    Kim, Theresa W.
    Samet, Jeffrey H.
    Tsui, Judith I.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2023, 49 (04) : 511 - 518
  • [47] A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence
    Lintzeris, N.
    Leung, S. Y.
    Dunlop, A. J.
    Larance, B.
    White, N.
    Rivas, G. R.
    Holland, R. M.
    Degenhardt, L.
    Muhleisen, P.
    Hurley, M.
    Ali, R.
    DRUG AND ALCOHOL DEPENDENCE, 2013, 131 (1-2) : 119 - 126
  • [48] The clinical efficacy and abuse potential of combination buprenorphive-naloxone in the treatment of opioid dependence
    Mammen, Kristie
    Bell, James
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (15) : 2537 - 2544
  • [49] Outpatient buprenorphine induction and maintenance treatment for kratom dependence: A case study
    Agapoff, James R.
    Kilaru, Usha
    JOURNAL OF SUBSTANCE USE, 2019, 24 (06) : 575 - 577
  • [50] Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial
    Wang, XuYi
    Jiang, Haifeng
    Zhao, Min
    Li, Jing
    Gray, Frank
    Sheng, Lixia
    Li, Yi
    Li, Xiaodong
    Ling, Walter
    Li, Wei
    Hao, Wei
    ASIA-PACIFIC PSYCHIATRY, 2019, 11 (01)